Remdesivir for coronavirus 2019 (COVID-19): More promising but still unproven

From December 2019 to May 22, 2020 the emerging and ever-increasing pandemic of coronavirus 19 (COVID-19) had no effective and safe treatment. Not surprisingly, remdesivir attracted worldwide attention. In a trial published online ahead of print, of 1063 patients, 541 were assigned at random to remd...

Descripción completa

Detalles Bibliográficos
Autores principales: Shih, Richard D., Maki, Dennis G., Hennekens, Charles H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538864/
https://www.ncbi.nlm.nih.gov/pubmed/33043163
http://dx.doi.org/10.1016/j.conctc.2020.100663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538864/
https://www.ncbi.nlm.nih.gov/pubmed/33043163
http://dx.doi.org/10.1016/j.conctc.2020.100663

Ejemplares similares